Frontline Pharma: Sarah O’Keeffe Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients By James Strachan May 8, 2026 16 min The Analytical Scientist Share Summary Listen Insight Report Clinical Scorecard Quiz Top Institutions